Episode 34: A distinctly different treatment - Mark Lacey's approach to stage 4 prostate cancer
Update: 2025-07-14
Description
When Mark Lacey was diagnosed with metastatic prostate cancer, his PSA was 3,500 and his scan was lit up from head to toe. Less than a year later, most of the bone mets are gone. In this honest, hard-hitting conversation, Mark shares what worked and why he’s still here — still farming, still thinking, still fighting.
Orchiectomy causes a flatline in testosterone, but doesn’t interfere with the brain’s signaling loop.
This stabilizes hormonal levels — no peaks, valleys, or drug half-lives to manage.
In some men, this steady state reduces cognitive side effects that were present on drug-based ADT.
Orchiectomy eliminates fluctuations
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
